Androgen deprivation therapy: Not associated with increased risk of Alzheimer disease

The use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease, a large-scale, population based study has concluded….

The use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease, a large-scale, population based study has concluded….